Praveen Tyle - 22 Jul 2021 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/Praveen Tyle, Ph.D.
Issuer symbol
SKYE
Transactions as of
22 Jul 2021
Net transactions value
$0
Form type
4
Filing time
26 Jul 2021, 14:23:44 UTC
Next filing
16 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Director Option Grant (Right to Buy) Award $0 +250,000 $0.000000 250,000 22 Jul 2021 Common Stock 250,000 $0.1400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each of the Options shall be exercisable for a price of $0.14 per Option Share for ten years from July 22, 2021 (the "Grant Date") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over two years.